Javascript must be enabled to continue!
Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination
View through CrossRef
OBJECTIVES:
The study objective was evaluation of amotosalen and ultraviolet A (UVA) illumination-based inactivation of dengue virus (DENV) in blood platelets.
MATERIALS AND METHODS:
Whole blood was collected from healthy donors and platelet concentrates were prepared at a tertiary care hospital in Gurugram, India. Platelet units collected from five blood group matched individuals were pooled and spiked with DENV. The spiked platelet units were subjected to amotosalen treatment followed by UVA illumination, to evaluate the efficiency of this method for viral inactivation. The treated platelet units were evaluated for the presence of infectious DENV. Amotosalen levels were quantified in the treated samples using high-performance liquid chromatography.
RESULTS:
The presence of replicating DENV was not observed in spiked platelet units treated with amotosalen and UVA illumination, whereas untreated units contained actively replicating DENV. Amotosalen levels were found to be in the permissible range after photochemical inactivation.
CONCLUSIONS:
Amotosalen/UVA pathogen inactivation treatment showed efficient inactivation of DENV in platelet components. Therefore, it seems to be a promising method for mitigating the risk of dengue transmission through transfusion of potentially contaminated platelet components in dengue-endemic countries such as India.
Title: Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination
Description:
OBJECTIVES:
The study objective was evaluation of amotosalen and ultraviolet A (UVA) illumination-based inactivation of dengue virus (DENV) in blood platelets.
MATERIALS AND METHODS:
Whole blood was collected from healthy donors and platelet concentrates were prepared at a tertiary care hospital in Gurugram, India.
Platelet units collected from five blood group matched individuals were pooled and spiked with DENV.
The spiked platelet units were subjected to amotosalen treatment followed by UVA illumination, to evaluate the efficiency of this method for viral inactivation.
The treated platelet units were evaluated for the presence of infectious DENV.
Amotosalen levels were quantified in the treated samples using high-performance liquid chromatography.
RESULTS:
The presence of replicating DENV was not observed in spiked platelet units treated with amotosalen and UVA illumination, whereas untreated units contained actively replicating DENV.
Amotosalen levels were found to be in the permissible range after photochemical inactivation.
CONCLUSIONS:
Amotosalen/UVA pathogen inactivation treatment showed efficient inactivation of DENV in platelet components.
Therefore, it seems to be a promising method for mitigating the risk of dengue transmission through transfusion of potentially contaminated platelet components in dengue-endemic countries such as India.
Related Results
CLINICAL COURSE AND OUTCOME OF PATIENTS WITH DENGUE FEVER, DENGUE HEMORRHAGIC FEVER AND DENGUE SHOCK SYNDROME IN A TERTIARY CARE HOSPITAL IN RECENT ENDEMIC 2022
CLINICAL COURSE AND OUTCOME OF PATIENTS WITH DENGUE FEVER, DENGUE HEMORRHAGIC FEVER AND DENGUE SHOCK SYNDROME IN A TERTIARY CARE HOSPITAL IN RECENT ENDEMIC 2022
Background: Dengue fever cases have been increased almost 30-fold over last 50 years and now reaches an estimated 100 million clinically apparent infections annually. This rapid in...
Dengue spatial dynamics : the example of Northern Vietnam
Dengue spatial dynamics : the example of Northern Vietnam
Dynamique spatiale de la dengue : l'exemple du Nord Vietnam
Alors que l’épidémiologie de la dengue dans le sud du Vietnam est caractérisée par un régime d’hyper-end...
DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus v1
DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus v1
Background Amplicon-based sequencing (PrimalSeq) was developed in response to the Zika virus epidemic due to difficulties generating complete genomes using metagenomic approaches [...
DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus v2
DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus v2
Version 2 updates: Updated the DENV3 primer file (DENV3_Primer-Scheme.xlsx) with correct version Background Amplicon-based sequencing (PrimalSeq) was developed in response to the...
INFEKSI VIRUS DENGUE PADA ANAK DI BLU PROF. DR. R. D KANDOU MANADO PERIODE JULI 2011 SAMPAI JUNI 2012
INFEKSI VIRUS DENGUE PADA ANAK DI BLU PROF. DR. R. D KANDOU MANADO PERIODE JULI 2011 SAMPAI JUNI 2012
Abstract: More than a third of the world's population live in areas at risk of infection. Dengue virus is a major cause of illness and death in the tropics and subtropics. As many ...
Evolutionary dynamics of dengue virus in India
Evolutionary dynamics of dengue virus in India
Abstract
More than a hundred thousand dengue cases are diagnosed in India annually, and about half of the country’s population carries dengue virus-specific antibod...
Spatial and epidemiologic features of dengue in Sabah, Malaysia
Spatial and epidemiologic features of dengue in Sabah, Malaysia
Abstract
In South East Asia, dengue epidemics have increased in size and geographical distribution in recent years. Most studies investigating de...
A human
ex vivo
dengue virus neutralization assay identifies priority antibodies and epitopes for vaccines and therapeutics
A human
ex vivo
dengue virus neutralization assay identifies priority antibodies and epitopes for vaccines and therapeutics
Abstract
Background
Dengue is the most prevalent arboviral disease, for which neither effective vaccines nor antivirals are ava...

